David Lamond
CIK 1770790 · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$448.1K
Companies
4
Total Filings
29
Lifetime Open-Market Net
$9.92M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QNCX | Director | 23,136 | $19.37 | $448.1K | $601.5K | 11 | 2026-06-15 |
| Quince Therapeutics, Inc. (CRTX) Delisted | Director | 2,036,551 | $1.95 | $3.97M | $8.05M | 11 | 2022-06-09 |
| Lucira Health, Inc. (LHDX) Delisted | Director | 178,910 | $0.45 | $80.9K | $0 | 2 | 2022-06-03 |
| Applied Molecular Transport Inc. (AMTI) Delisted | Director | 1,044,019 | $0.26 | $274.6K | $1.26M | 5 | 2022-05-26 |
Recent Filings · Page 2 of 3
29 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-26 | QNCX | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | Quince Therapeutics, Inc. (CRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-03 | Lucira Health, Inc. (LHDX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-26 | Applied Molecular Transport Inc. (AMTI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-23 | Quince Therapeutics, Inc. (CRTX) Delisted | Grant (A) | +200,002 | $0 | EDGAR |
| 2022-05-23 | Applied Molecular Transport Inc. (AMTI) Delisted | Buy (P) | +66,500 | $210.8K | EDGAR |
| 2021-06-17 | Quince Therapeutics, Inc. (CRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-20 | Applied Molecular Transport Inc. (AMTI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-07 | Applied Molecular Transport Inc. (AMTI) Delisted | Buy (P) | +25,000 | $1.05M | EDGAR |
| 2021-03-24 | Quince Therapeutics, Inc. (CRTX) Delisted | Buy (P) | +50,000 | $1.69M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.